RETROVIRUSES NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


RETROVIRUSES

Eighteenth Meeting of the European Tumor Virus Group. April 30-May 4, 1989, Sundbyholm's Castle, Sweden, Swedish Cancer Society, 1989.. Unique Identifier : AIDSLINE ICDB/90660587
Anonymous; No affiliation given

Abstract: Abstracts are presented for the 18th European Tumor Virus Group meeting held April 30-May 4, 1989, in Sweden. Titles for the portion of the meeting covering retroviruses include a murine leukemia virus (MuLV) transmission vector system designed to analyze the integration pattern of retroviruses and their potential activation of oncogenes; the phenotype of rat T-cell lymphomas induced by Moloney murine leukemia virus (MoMuLV: several stages of T-cell development); paralysis induced in mice by a MuLV; bovine leukemia virus (BLV) transcription (development of an in vitro system); infection of adult rats with BLV (establishment of a rat BLV-producing cell line); simian T-lymphotropic virus-I-associated T- and B-cell baboon malignant lymphoma (direct or indirect role for retrovirus in lymphomagenesis); determination of human T-lymphotropic virus (HTLV)-I infection in patients with different blood pathologies; association of HTLV-I with various forms of hemoblastoses; improved assays for DNA-polymerizing enzymes using enzymatically synthesized 5-125I-iododeoxyuridine triphosphate (direct quantitation of anti-HIV-RT antibody); salivary antibodies to HIV in patients with, or at risk for, AIDS; enhancement of retrovirus-induced cell fusion by proteases; effect of heat-shock on HIV-1 replication cycle; regulation of HTLV-I expression in an infected cell line by methylation; effect of avian erythroblastosis virus on the cell-mediated immunity of chickens and turkeys; association of provirus insertion in a novel locus of common integration (tpl-1) with tumor progression in MoMuLV-induced thymic lymphomas; BLV-packaging cell line for retroviral-mediated gene transfer; sequence and antigenic drift of the BLV env glycoproteins and their inference on a three-dimensional model; a single-tube, one-step purification and assay system for the analysis of reverse transcriptase activity in crude specimens and some applications with reference to HIV; and human receptors for retroviruses.
Keywords: Animal Cell Line, Transformed Cell Transformation, Neoplastic/*GENETICS Cell Transformation, Viral/*GENETICS Gene Expression Regulation, Viral/PHYSIOLOGY Genes, Viral/PHYSIOLOGY Human HIV/GENETICS HTLV-I/GENETICS Retroviridae/*GENETICS MONOGRAPHKWDanimalcellline,transformedcelltransformation,neoplastic/KWDgeneticscelltransformation,viral/KWDgeneticsgeneexpressionregulation,viral/physiologygenes,viral/physiologyhumanhiv/geneticshtlv-i/geneticsretroviridae/KWDgeneticsmonograph
900530
M9051012

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .